Reduction of Polypharmacy in Elderly People With Multiple Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age70+
SponsorMartin-Luther-Universität Halle-Wittenberg
About this trial
Elderly GP patients are often treated with five or more medications and therefore prone to adverse drug reactions (ADR). Potentially inappropriate prescriptions (PIPs) lead to increased adverse events like falls, hospitalizations and mortality. The primary aim of this study to reduce the frequency of ADRs in multimorbid patients aged 70 years and older by reducing polypharmacy.
Eligibility criteria
Qualifiers
≥ 5 longterm medications (> 6 months) (polypharmacy)
≥ 3 chronic diseases (multimorbidity)
≥ 1 family doctor consultation within the last 6 months
Disqualifiers
Patients with a critically reduced life expectancy
Patients who cannot autonomously visit the family practice
Patients who cannot participate in the informed consent process
Patients who are residing in a nursing home
Trial design
Treatments tested in this trial
- Medication plan review
- Adherence support
Treatment groups
1,146 Participants
are divided into 2 treatment groupsSponsors and collaborators
Martin-Luther-Universität Halle-Wittenberg
Lead sponsor
University of Leipzig
Collaborator
Hannover Medical School
Collaborator
Source ClinicalTrials.gov